SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001504167-16-000013
Filing Date
2016-12-19
Accepted
2016-12-19 16:12:42
Documents
4
Period of Report
2016-12-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bpmx-20161214x8k.htm 8-K 32069
2 EX-10.1 bpmx-20161214ex101f7d707.htm EX-10.1 167857
3 GRAPHIC bpmx20161214ex101f7d707001.jpg GRAPHIC 152775
4 GRAPHIC bpmx20161214ex101f7d707002.jpg GRAPHIC 129465
  Complete submission text file 0001504167-16-000013.txt   589973
Mailing Address 1098 HAMILTON COURT MENLO PARK CA 94025
Business Address 1098 HAMILTON COURT MENLO PARK CA 94025 650-889-5020
BioPharmX Corp (Filer) CIK: 0001504167 (see all company filings)

IRS No.: 593843182 | State of Incorp.: DE | Fiscal Year End: 0131
Type: 8-K | Act: 34 | File No.: 001-37411 | Film No.: 162059089
SIC: 2834 Pharmaceutical Preparations